The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron- specific enolase in patients with advanced non-small-cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Expression of immunohistochemical markers chromogranin A, Ki-67, CD99, EGFR in resected pulmonary neuroendocrine tumors Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Serum neuron-specific enolase - a marker for disease extent and response to therapy of small-cell lung cancerSource: Eur Respir J 2004; 24: Suppl. 48, 76s Year: 2004
Clinical correlates and prognostic significance of neuron specific enolase (NSE) in non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002
Contribution of immunohistochemical (IHC) markers to the diagnosis of pulmonary carcinoids Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
The impact of smoking on the pulmonary neuroendocrine system assessed by serum levels of chromogranin A Source: Eur Respir J 2005; 26: Suppl. 49, 484s Year: 2005
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Serum napsin A as a tumor marker for primary lung adenocarcinoma Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Neuroendocrine differentiation in non-small cell lung cancer. A biochemical, immunohistological and ultrastructural evaluation of Chromogranin A Source: Eur Respir J 2006; 28: Suppl. 50, 783s Year: 2006
Neuron-specific enolase (NSE) serum level as a prognostic factor for tumor regression and survival in non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002
Potential prognostic factors in typical and atypical carcinoid tumours of the lung - immunhistochemical investigations Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001
Smoking status and serum NSE, as prognostic factors in adenocarcinoma of lung Source: Eur Respir J 2005; 26: Suppl. 49, 325s Year: 2005
Prognostic significance of MUC1 expression in resected lung adenocarcinoma Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003
Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma Source: Eur Respir J 2013; 41: 943-951 Year: 2013
Serum napsin A is a novel diagnostic and monitoring marker for interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Prognostic significance of p53 and Ki-67 expression in Patients with Resected Lung squamous cell carcinoma Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017